ARTICLE | Clinical News
Keyzilen esketamine hydrochloride: Phase III data
August 22, 2016 7:00 AM UTC
Top-line data from the double-blind, international Phase III TACTT2 trial in 343 patients with acute inner ear tinnitus following traumatic cochlear injury or otitis media showed that showed that repe...